E-cigarette vapor tied to changes in lung cells
(Reuters Health) – The vapor from e-cigarettes may boost the production of inflammatory chemicals in the lungs, while disabling key cellular defenders against infection, a new study suggests. In a…
by October Gallery
(Reuters Health) – The vapor from e-cigarettes may boost the production of inflammatory chemicals in the lungs, while disabling key cellular defenders against infection, a new study suggests. In a…
LONDON (Reuters) – Biogen’s muscle disease treatment Spinraza has been deemed too expensive for use on Britain’s state-run health service, even after a price discount offered by the U.S. drugmaker.…
LONDON/PARIS (Reuters) – An escalating trade war between the United States and China could abruptly end a glittering stock market run for luxury goods firms, with some investors already put…
LONDON (Reuters) – Alarm bells were ringing on Thursday as harsh new U.S. sanctions drove drove down Russia’s rouble Turkey’s lira plunged as worries mounted that Ankara was sliding towards…
NEW YORK (Reuters) – Stock markets lifted on Monday after strong corporate earnings helped Wall Street close higher, but a tariff dispute between the United States and China limited gains…
LONDON/SAN FRANCISCO (Reuters) – Huawei Technologies is facing increased scrutiny in Britain because it is using an aging software component sold by a firm based in the United States, one…
PARIS/ZURICH/LONDON (Reuters) – Sanofi (SASY.PA) and Novartis (NOVN.S) said on Wednesday they planned to increase stockpiles of medicines in Britain in preparation for potential disruption if the UK crashes out…
Documents show that U.S. President Donald Trump‘s family business has “destroyed the vast majority” of an environmentally sensitive area of sand dunes near its golf course north of Aberdeen in…
DUBLIN (Reuters) – Ryanair (RYA.I) has told more than 300 pilots and cabin crew that they risk losing their jobs as it cuts its Dublin-based fleet by 20 percent for…
LONDON (Reuters) – GlaxoSmithKline’s new research boss aims to turbo-charge the British group’s drug discovery engine with a $300 million bet on genetics by buying a stake in the Silicon…